Volume 17, Number 1—January 2011
Letter
Emergence of New Delhi Metallo-β-Lactamase, Austria
Gernot Zarfel, Martin Hoenigl, Eva Leitner, Helmut J.F. Salzer, Gebhard Feierl, Lilian Masoud, Thomas Valentin, Robert Krause, and Andrea J. Grisold
Table
Antimicrobial drug susceptibilities of New Delhi metallo-β-lactamase strains isolated from 2 patients, Graz, Austria, 2010*
| Drug |
MIC, mg/L |
|
| Patient 1 isolate |
Patient 2 isolate |
|
| Colistin | 0.125 | 0.125 |
| Tigecycline | 2 | 0.125 |
| Amikacin | 8 | 2 |
*Only substances for which isolates had susceptibility are listed. MICs were determined by the Etest method (AB BIODISK, Solna, Sweden). Susceptibility was determined according to relevant testing conditions and the new susceptibility interpretation standards proposed by the Clinical and Laboratory Standards Institute (www.clsi.org).
1These authors contributed equally to this work.
Page created: July 08, 2011
Page updated: July 08, 2011
Page reviewed: July 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.